CAS 76963-41-2; 尼扎替丁; 1,1-ethenediamine, n-(2-(((2-((dimethylamino)methyl)-4-thiazolyl)methyl)thio)et

推荐供应商

货号

品牌

产品名称

规格

包装、参考价格

N795367

MACKLIN

尼扎替丁

10mM in DMSO

463元/1ml;

咨询

储存：-20°C

N0933

TCI

Nizatidine

>97.0%(T)(HPLC)

395元/5G; 1590元/25G;

咨询

基本信息

纯度/分析方法	>97.0%(T)(HPLC)
分子式/分子量	C₁₂H₂₁N₅O₂S₂ = 331.45
外观与形状(20℃)	固体
储存在惰性气体下	存放于惰性气体之中
应避免的情况	空气
Reaxys-RN	4846056
PubChem物质ID	253661718
Merck Index (14)	6660
MDL编号	MFCD00865660

技术规格

Appearance	White to Light yellow powder to crystal
Purity(HPLC)	min. 97.0 area%
Purity(Nonaqueous Titration)	min. 97.0 %
Melting point	130.0 to 134.0 ℃

物性(参考值)

熔点	132 ℃
水溶性	微溶
溶解性(易溶于)	二甲基甲酰胺
溶解性(可溶于)	甲醇,二氯甲烷
溶解度(极微溶)	乙醇,丙酮
溶解性(不溶于)	乙醚

安全信息

图形或危害标志
信号词	警告
危险性说明	H302 : 吞咽有害。
防范说明	P501 : 将内装物/容器送到批准的废物处理厂处理。 P270 : 使用本产品时不要进食、饮水或吸烟。 P264 : 作业后彻底清洗皮肤。 P301 + P312 + P330 : 如误吞咽：如感觉不适，呼叫急救中心/医生。漱口。

相关法规

RTECS#

KM6565000

429548

J&K

Nizatidine

99%

436元/5G; 1511元/25G; 4976元/100G;

咨询

基本信息

分子式	C₁₂H₂₁N₅O₂S₂
分子量	331.46
熔点	130-134
MDL编码	MFCD00865660
Beilstein	4846056
Merck	14, 6660

安全信息

图形或危害标志
危险说明	H302
防范说明	P264 P270 P301+P312+P330 P501
RTECS	KM6565000

C46847

Alfa Aesar

Nizatidine

2635元/5g; 7063元/25g;

咨询

基本信息

分子式
C12 H21 N5 O2 S2

分子量
331.45

N1090000

Nizatidine

European Pharmacopoeia (EP) Reference Standard

1286.46元/ ;

咨询

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

包装

Unit quantity: 250 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式	C₁₂H₂₁N₅O₂S₂
分子量	331.46
NACRES	NA.24

产品性质

等级	pharmaceutical primary standard
manufacturer/tradename	EDQM
application(s)	pharmaceutical (small molecule)
格式	neat
储存温度	2-8℃
InChI	1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3/b11-6+
InChI key	SGXXNSQHWDMGGP-IZZDOVSWSA-N

安全信息

象形图
警示用语：	Warning
危险声明	H302
预防措施声明	P264 - P270 - P301 + P312 - P501
危险分类	Acute Tox. 4 Oral
储存分类代码	11 - Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable

Y0001278

Nizatidine for system suitability

European Pharmacopoeia (EP) Reference Standard

1176.99元/ ;

咨询

产品说明

一般描述

包装

Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式	C₁₂H₂₁N₅O₂S₂
分子量	331.46
NACRES	NA.24

产品性质

等级	pharmaceutical primary standard
manufacturer/tradename	EDQM
application(s)	pharmaceutical (small molecule)
格式	neat
储存温度	2-8℃
InChI	1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3/b11-6+
InChI key	SGXXNSQHWDMGGP-IZZDOVSWSA-N

安全信息

象形图
警示用语：	Warning
危险声明	H302
预防措施声明	P264 - P270 - P301 + P312 - P501
危险分类	Acute Tox. 4 Oral
储存分类代码	11 - Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable

N7035

Supelco

Nizatidine

analytical standard

591.92元/5 G;

咨询

产品说明

应用

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
Histamine H2 receptor antagonist. Used to treat gastroesophogeal reflux disease by preventing release of acid and pepsin into the stomach.

包装

5, 10 g in glass bottle

基本信息

经验(实验)分子式	C₁₂H₂₁N₅O₂S₂
分子量	331.46
MDL编号	MFCD00865660
PubChem化学物质编号	329818669
NACRES	NA.24

产品性质

等级	analytical standard
质量水平	100
technique(s)	HPLC: suitable gas chromatography (GC): suitable
application(s)	pharmaceutical (small molecule)
格式	neat
SMILES string	CN\C(NCCSCc1csc(CN(C)C)n1)=C/[N+]([O-])=O
InChI	1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3/b11-6+
InChI key	SGXXNSQHWDMGGP-IZZDOVSWSA-N

安全信息

象形图
警示用语：	Warning
危险声明	H302
预防措施声明	P264 - P270 - P301 + P312 - P501
危险分类	Acute Tox. 4 Oral
储存分类代码	11 - Combustible Solids
WGK	WGK 3
个人防护装备	dust mask type N95 (US), Eyeshields, Gloves

SML2960

Sigma-Aldrich

Nizatidine

≥98% (HPLC)

416.36元/500 MG;

咨询

产品说明

生化/生理作用

Nizatidine is a potent and selective antagonist of histamine H2 receptors used for treatment of stomach and intestine ulcers. Also, it was recommended as a component of combination therapy for cancer treatment. New data indicate that it can be repurposed to treat subtypes of clear cell renal cell carcinoma (ccRCC) in patients expressing certain isoforms of the pyruvate kinase muscle type. Additionally, nizatidine increases utrophin A levels in in C2C12 myoblasts (relevant to Duchenne muscular dystrophy).

基本信息

经验(实验)分子式	C₁₂H₂₁N₅O₂S₂
分子量	331.46

产品性质

质量水平	100
测定	≥98% (HPLC)
形式	powder
颜色	white to beige
溶解性	DMSO: 2 mg/mL, clear
储存温度	2-8℃
InChI	1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3/b11-6+
InChI key	SGXXNSQHWDMGGP-IZZDOVSWSA-N

安全信息

象形图
警示用语：	Warning
危险声明	H302
预防措施声明	P264 - P270 - P301 + P312 - P501
危险分类	Acute Tox. 4 Oral
储存分类代码	11 - Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable

1467804

USP

Nizatidine

United States Pharmacopeia (USP) Reference Standard

7060.47元/200 MG;

咨询

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

分析说明

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

其他说明

USP issued SDS can be found here.
Sales restrictions may apply.

基本信息

经验(实验)分子式	C₁₂H₂₁N₅O₂S₂
分子量	331.46
NACRES	NA.24

产品性质

等级	pharmaceutical primary standard
manufacturer/tradename	USP
application(s)	pharmaceutical (small molecule)
格式	neat
InChI	1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3/b11-6+
InChI key	SGXXNSQHWDMGGP-IZZDOVSWSA-N

安全信息

象形图
警示用语：	Warning
危险声明	H302
预防措施声明	P264 - P270 - P301 + P312 - P501
危险分类	Acute Tox. 4 Oral
储存分类代码	11 - Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable

358089

Fluorochem

[1-({2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)sulfanyl]ethyl}amino)-2-nitroethenyl](methyl)amine

>97.0%(HPLC)(T)

968元/5g; 3190元/25g;

咨询

基本信息

CAS Number	76963-41-2
MDL Number	MFCD00865660